表紙画像

Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis via Attenuating Osteoclastogenesis and ROS Generation

Osteoporosis (OP) is one of the common bone metabolic diseases that endangers postmenopausal women and the elders. Both excessive bone resorption caused by osteoclast over-activation and increased oxidative stress are associated with osteoporosis. Cinnamtannin B-1 (CB-1) is considered as a high-valu...

保存先:

書誌詳細
主要な著者:	Meng Li (著者), Li Hao (著者), Lei Li (著者), Lei Liu (著者), Guang Chen (著者), Wei Jiang (著者), Wei Xu (著者), Chen Zhu (著者), Gang Yao (著者), Shiyuan Fang (著者)
フォーマット:	図書
出版事項:	Frontiers Media S.A., 2020-07-01T00:00:00Z.
主題:	article
オンライン･アクセス:	Connect to this object online.
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
著者:: Guobin Qi, 等
出版事項: (2022)

Traditional Chinese decoction Si Zhi Wan attenuates ovariectomy (OVX)-induced bone loss by inhibiting osteoclastogenesis and promoting apoptosis of mature osteoclasts
著者:: Qingman He, 等
出版事項: (2022)

Theaflavin-3, 3'-Digallate Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Ovariectomy-Induced Bone Loss in Mice
著者:: Zexin Ai, 等
出版事項: (2020)

Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro
著者:: Titi Liu, 等
出版事項: (2017)

α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis
著者:: Hao Tian, 等
出版事項: (2022)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
著者:: Jun-ming Huang, 等
出版事項: (2018)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
著者:: Jia Wang, 等
出版事項: (2020)

Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
著者:: Jiachao Guo, 等
出版事項: (2017)

Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling
著者:: Bin Pan, 等
出版事項: (2021)

Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
著者:: Jun-ming Huang, 等
出版事項: (2018)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
著者:: Qiang Xu, 等
出版事項: (2021)

Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation
著者:: Qiuwei Peng, 等
出版事項: (2023)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
著者:: Dahu Qi, 等
出版事項: (2021)

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
著者:: Jiachao Guo, 等
出版事項: (2018)

Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
著者:: Min Ma, 等
出版事項: (2022)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
著者:: Chenhui Cai, 等
出版事項: (2021)

A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model
著者:: Guoju Hong, 等
出版事項: (2023)

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
著者:: Bao Huang, 等
出版事項: (2019)

Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation
著者:: Qi He, 等
出版事項: (2024)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
著者:: Yunfei Zhan, 等
出版事項: (2020)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
著者:: Wei Wang, 等
出版事項: (2020)

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
著者:: Wei Lin, 等
出版事項: (2021)

Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
著者:: Wang Yajun, 等
出版事項: (2021)

Physcion effectively mitigates ovariectomy-induced osteoporosis in mice
著者:: Yun-Ho Hwang, 等
出版事項: (2020)

Jin-Tian-Ge ameliorates ovariectomy-induced bone loss in rats and modulates osteoblastogenesis and osteoclastogenesis in vitro
著者:: Yi Shen, 等
出版事項: (2022)

6'-O-Galloylpaeoniflorin Attenuates Osteoclasto-genesis and Relieves Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species and MAPKs/c-Fos/NFATc1 Signaling Pathway
著者:: Wenjie Liu, 等
出版事項: (2021)

Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways
著者:: Dingwei Cang, 等
出版事項: (2021)

A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
著者:: Zhi Xin, 等
出版事項: (2018)

Muscone Ameliorates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κb Ligand-Induced Osteoclastogenesis by Suppressing TNF Receptor-Associated Factor 6-Mediated Signaling Pathways
著者:: Xiao Zhai, 等
出版事項: (2020)

Olive Oil effectively mitigates ovariectomy-induced osteoporosis in rats
著者:: Saleh Hanan A, 等
出版事項: (2011)

Clofibrate Attenuates ROS Production by Lipid Overload in Cultured Rat Hepatoma Cells
著者:: Yufei Chen, 等
出版事項: (2017)

Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages
著者:: Huaqiang Tao, 等
出版事項: (2022)

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
著者:: Zhi Xin, 等
出版事項: (2021)

Herbal formula xuling-jiangu improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the gut-bone axis
著者:: Juan Chen, 等
出版事項: (2024)

Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway
著者:: Jing Sun, 等
出版事項: (2021)

The Novel Antioxidant Compound JSH-23 Prevents Osteolysis by Scavenging ROS During Both Osteoclastogenesis and Osteoblastogenesis
著者:: Liangwei Mei, 等
出版事項: (2021)

Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway
著者:: Junwen Han, 等
出版事項: (2022)

Corrigendum to "Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis" [Pharm. Res. 108 (2016) 90-101]
著者:: Xufeng Tao, 等
出版事項: (2023)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
著者:: Gang Wang, 等
出版事項: (2022)

Biochanin A Attenuates Ovariectomy-Induced Cognition Deficit via Antioxidant Effects in Female Rats
著者:: Yanmeng Zhou, 等
出版事項: (2021)